Search Medical Condition
Please enter condition
Please choose location from dropdown

New Albany, Ohio Clinical Trials

A listing of New Albany, Ohio clinical trials actively recruiting patient volunteers.

RESULTS

Found (185) clinical trials

Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System

The purpose of this study is to determine if electrical stimulation (small levels of electricity) in addition to the standard of care can safely and effectively reduce pain following total knee replacement more than the standard of care, alone. This study involves a device called the SPRINT Beta System. The ...

Phase N/A

0.0 miles

Learn More »

Navio With Total Knee Arthroplasty

Total Knee Arthroplasty (TKA) has become an effective and reliable treatment for arthritis of the knee (1). TKA is associated with low morbidity and mortality, and its effectiveness in reducing joint pain and improving range of motion is well established. In 2014, over 750,000 knee replacements were performed in the ...

Phase N/A

0.0 miles

Learn More »

Saline-Controlled Study of nSTRIDE APS for Knee Osteoarthritis

A double-blind, multicenter, randomized, saline-controlled trial (RCT) that will evaluate the efficacy of a single dose of Autologous Protein Solution (APS) in patients with symptomatic osteoarthritis (OA) of the knee who have not been able to get satisfactory pain relief with prior treatment.

Phase N/A

0.0 miles

Learn More »

Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain

Low back pain (LBP) is a common complaint in adolescent athletes, with rates reported as high as 50% by the mid-teen years. Although low back pain in adolescent athletes may result from several different pathologies, spondylolysis--a fracture at the pars interarticularis--is the most common cause in this demographic, with a ...

Phase N/A

0.0 miles

Learn More »

MUA to Treat Postoperative Stiffness After Total Knee Arthroplasty

Stiffness is a potential complication following Total Knee Arthroplasty (TKA). While a variety of factors have been cited as possible causes, such as component malrotation or improper soft-tissue balancing, however, an etiology is not always appreciated. Histologic and arthroscopic evidence of fibrosis suggests that an inflammatory process may contribute to ...

Phase N/A

0.0 miles

Learn More »

Oxford Signature vs. Conventional Global Study

The primary objectives of this global clinical study are to collect data to assess the following clinical evidence parameters that were gathered from Biomet team members and KOL globally for this product: 1. Evaluate the performance & accuracy of the Oxford Partial Knee System with Signature Knee Guide in comparison ...

Phase N/A

0.0 miles

Learn More »

Evaluation of a Treatment Algorithm for Patients With Patellofemoral Pain Syndrome

Patellofemoral pain syndrome (PFPS) accounts for 25 to 40% of knee pain in young and active individuals. PFPS is described as anterior knee pain around the patella which is aggravated by activity, particularly activities that increase patellofemoral forces such as squatting, ascending or descending stairs, running, and jumping. It is ...

Phase N/A

0.0 miles

Learn More »

Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms

Ten year safety study examining rates of rare adverse events, child bearing issues, effects of mammography, MRI compliance and results, and long-term benefit of silicone-filled breast implants.

Phase N/A

5.21 miles

Learn More »

Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis

The purpose of this study is to evaluate the safety and efficacy of ixekizumab in pediatric participants with moderate-to-severe plaque psoriasis.

Phase

5.21 miles

Learn More »

An Open-Label Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum

This is a Phase II study that will be open label and include a total of five patients who will receive the investigational product. These patients will have histological testing to rule out competing etiologies and require 3rd party adjudication/confirmation on agreement of the diagnosis. These patients will undergo 12 ...

Phase

5.21 miles

Learn More »